CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response.
Open Access
- 1 May 1996
- journal article
- research article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 183 (5) , 2129-2142
Abstract
The ligand for CD40 (CD40L) is expressed on the surface of activated CD4+ T cells and its role in T-B cell collaborations and thymus-dependent humoral immunity is well established. Recently, by generating CD40L-knockout mice, we have confirmed its previously described role in humoral immunity and defined another important function of this molecule in the in vivo clonal expansion of antigen-specific CD4+ T cells. Here, we investigated the potential in vivo role of CD40L in antiviral immunity by examining the immune response mounted by CD40L-deficient mice following infection with lymphocytic choriomeningitis virus (LCMV), Pichinde virus, or vesicular stomatitis virus. Humoral immune responses of CD40L-deficient mice to these viruses were severely compromised, although moderate titres of antiviral IgM and some IgG2a were produced by virus-infected CD40L-deficient mice by a CD4+ T cell-independent mechanism. By contrast, CD40L-deficient mice made strong primary CTL responses to all three viruses. Interestingly however, although memory CTL activity was detectable in CD40L-deficient mice two months after infection with LCMV, the memory CTL response was much less efficient than in wild-type mice. Together, the results show that CD40-CD40L interactions are required for strong antiviral humoral immune responses, and reveal a novel role for CD40L in the establishment and/or maintenance of CD8+ CTL memory.Keywords
This publication has 48 references indexed in Scilit:
- CD40-CD40 Ligand: A Multifunctional Receptor-Ligand Pair1996
- Induction of bcl-x by CD40 engagement rescues sIg-induced apoptosis in murine B cellsThe Journal of Immunology, 1995
- T Cell-Independent Antigens Type 2Annual Review of Immunology, 1995
- Antibody mediated suppression of secondary IgM response in nude mice against vesicular stomatitis virus.The Journal of Immunology, 1986
- Therapy with monoclonal antibodies by elimination of T-cell subsets in vivoNature, 1984
- Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence.Journal of Experimental Medicine, 1984
- Genomic and Biological Variation among Commonly Used Lymphocytic Choriomeningitis Virus StrainsJournal of General Virology, 1983
- The interactionof antiody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies.1982
- The glycoprotein isolated from vesicular stomatitis virus is mitogenic for mouse B lymphocytes.Journal of Experimental Medicine, 1981
- Protein structure of lymphocytic choriomeningitis virus: Evidence for a cell-associated precursor of the virion glycopeptidesVirology, 1979